Could CBD offer relief for endometriosis and pelvic pain? a trial investigates

NCT ID NCT07728695

Recruiting now Symptom relief Sponsor: Staci Gruber, Ph.D. Source: ClinicalTrials.gov ↗

First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time

Summary

This trial tests whether a custom-formulated, high-CBD hemp product can reduce pain in women with endometriosis, adenomyosis, or chronic pelvic inflammatory disease. Over 7 days, participants receive either the CBD product or a placebo. Researchers will measure how the body processes CBD and track changes in pain and inflammation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: a custom-formulated, high-CBD hemp-derived product
What this could lead to: If it works, this could point toward a new, plant-based option for managing chronic gynecologic pain.
What could go wrong: This is an early-phase trial with only 60 participants and a short 7-day treatment period, so results may not apply broadly. CBD can cause side effects like drowsiness or digestive issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADENOMYOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

adenomyosis endometriosis pelvic inflammatory disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADENOMYOSIS CHRONIC PELVIC INFLAMMATORY DISEASE ENDOMETRIOSIS

Contacts and locations

Locations

McLean Hospital
RECRUITING

Belmont, Massachusetts, 02478, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.